1-161509955-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001136219.3(FCGR2A):āc.500A>Gā(p.His167Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.503 in 1,613,712 control chromosomes in the GnomAD database, including 206,994 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001136219.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR2A | NM_001136219.3 | c.500A>G | p.His167Arg | missense_variant | 4/7 | ENST00000271450.12 | NP_001129691.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR2A | ENST00000271450.12 | c.500A>G | p.His167Arg | missense_variant | 4/7 | 1 | NM_001136219.3 | ENSP00000271450.6 |
Frequencies
GnomAD3 genomes AF: 0.502 AC: 76314AN: 151928Hom.: 19447 Cov.: 32
GnomAD3 exomes AF: 0.476 AC: 119499AN: 251224Hom.: 29024 AF XY: 0.471 AC XY: 63904AN XY: 135776
GnomAD4 exome AF: 0.503 AC: 734636AN: 1461666Hom.: 187529 Cov.: 106 AF XY: 0.498 AC XY: 361788AN XY: 727142
GnomAD4 genome AF: 0.502 AC: 76380AN: 152046Hom.: 19465 Cov.: 32 AF XY: 0.498 AC XY: 37037AN XY: 74304
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Variant reported as a risk factor for lupus nephritis, severe malaria, p. aeurginosa infection, and reduced risk for ulcerative colitis - questionable and unrelated to patient disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Lupus nephritis, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2010 | - - |
Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2010 | - - |
Malaria, severe, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2010 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at